BioCentury
ARTICLE | Financial News

Ambit proposes IPO

November 15, 2010 8:00 AM UTC

Ambit Biosciences Corp., San Diego, Calif. Business: Cancer Date announced: 11/5/10 Type: IPO To be raised: Up to $86.3 million Price: TBD Underwriter: JPMorgan, Credit Suisse, Leerink, Wedbush Overal...